-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Integra Lifesciences, Lowers Price Target to $14

Benzinga·10/22/2026 19:14:34
Listen to the news
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Neutral and lowers the price target from $15 to $14.